Doxycycline treatment in a model of early abdominal aortic aneurysm

Surgery Today

Volumn 33, Issue 6, 2003, Pages 426-433

  Kaito, Keiko ^a   Urayama, Hiroshi ^a   Watanabe, Go ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Abdominal aortic aneurysm; Doxycycline

Indexed keywords

DOXYCYCLINE; ELASTIN; GELATINASE A; GELATINASE B;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; NONHUMAN; RAT; REMISSION;

ANIMALS; ANTI-BACTERIAL AGENTS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; DISEASE MODELS, ANIMAL; DOXYCYCLINE; ELASTIN; MALE; RATS; RATS, WISTAR;

EID: 0038021268     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10595-002-2513-0     Document Type: Article

References (26)

1. Thompson RW. Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem. Curr Opin Cardiol 1996;11:504-18.
2. Zatina MA, Zarins CK, Gewertz BL, Glagov S. Role of medial lamellar architecture in the pathogenesis of aortic aneurysms. J Vasc Surg 1984;1:442-8.
3. White JV, Haas K, Phillips S, Comerota AJ. Adventitial elastolysis is a primary event in aneurysm formation. J Vasc Surg 1993;17:371-80.
4. He CM, Roach MR. The composition and mechanical properties of abdominal aortic aneurysms. J Vasc Surg 1994;20:6-13.
5. Rosenbloom J, Abrams WR, Mecham R. Extracellular matrix 4: the elastic fiber. FASEB J 1993;7:1208-18.
6. McMillan WD, Patterson BK, Keen RR, Shively VP, Cipollone M, Pearce WH. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arterioscler Thromb Vasc Biol 1995;15:1139-44.
7. Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 1998;102:1900-10.
8. Anidjar S, Salzmann JL, Gentric D, Lagneau P, Camilleri JP, Michel JB. Elastase-induced experimental aneurysms in rats. Circulation 1990;82:973-81.
9. Sakalihasan N, Delvenne P, Nusgens BV, Limet R, Lapiere CM. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 1996;24:127-33.
10. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995;15:1145-51.
11. Boyle JR, McDermott E, Crowther M, Wills AD, Bell PR, Thompson MM. Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J Vasc Surg 1998;27:354-61.
12. Kasashima F, Urayama H. Matrix metaloproteinases and tissue inhibitors of metalloproteinases in atherosclerotic aortic aneurysm (in Japanese with English abstract). Kanazawadaigaku Juzenigakukaizasshi (J Juzen Med Soc) 1995;104:216-29.
13. Harada T, Urayama H. Studies of aortic aneurysm formation using experimental aortic aneurysms and atherosclerotic human aortas (in Japanese with English abstract). Kanazawadaigaku Juzenigakukaizasshi (J Juzen Med Soc) 1999;108:554-67.
14. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 1991;2:297-321.
15. Sorsa T, Ding Y, Salo T, Lauhio A, Teronen O, Ingman T, et al. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and Western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann N Y Acad Sci 1994;732:112-31.
16. Lovejoy B, Cleasby A, Hassell AM, Luther MA, Weigl D, McGeehan G, et al. Structural analysis of the catalytic domain of human fibroblast collagenase. Ann N Y Acad Sci 1994;732:375-8.
17. Curci JA, Mao D, Bohner DG, Allen BT, Rubin BG, Reilly JM, et al. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg 2000;31:325-42.
18. Huffman MD, Curci JA, Moore G, Kerns DB, Starcher BC, Thompson RW. Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms. Surgery 2000;128:429-38.
19. Campa JS, Greenhalgh RM, Powell JT. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 1987;65:13-21.
20. Nackman GB, Karkowski FJ, Halpern VJ, Gaetz HP, Tilson MD. Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model. Surgery 1997;122:39-44.
21. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 1995;96:318-26.
22. Curci JA, Petrinec D, Liao S, Golub LM, Thompson RW. Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg 1998;28:1082-93.
23. Herron GS, Unemori E, Wong M, Rapp JH, Hibbs MH, Stoney RJ. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler Thromb 1991;11:1667-77.
24. Anidjar S, Philip BD, Eichorst M, Galen P, Chejfec G. Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms. J Vasc Surg 1992;16:139-47.
25. Mosorin MM, Juvonen J, Biancari F, Satta J, Surcel HM, Leinomen M, et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg 2001;34:606-10.
26. MacSweeney ST, Ellis M, Worrell PC, Greenhalgh RM, Powell JT. Smoking and growth rate of small abdominal aortic aneurysms. Lancet 1994;344:651-2.